participants – Lab DB

AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.

Lana Keisha Sep 13, 2026 0

The landscape of hepatitis C (HCV) management has shifted significantly with the recent regulatory approvals of AbbVie’s direct-acting antiviral therapy,…

AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.

YOU MAY HAVE MISSED

Breakthrough Methodological Advances in Proteomics Unlock New Frontiers in Protein Dynamics, Sequencing, and Synthesis

AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.

Persistent financial hardship may speed up age-related cognitive decline, according to new research led by University College London (UCL).

Planet-Sized Physics: Japanese Researchers Turn Earth Into a Giant Detector to Hunt for Ultralight Dark Matter